E-DRUG: Prescrire International February Issue
----------------------------------------
The 2011 Prescrire Awards announced in Paris
Every year, Prescrire's Drug Awards showcase the new products that represent tangible progress for patients. Attributed in total independence by Prescrire's Editorial Staff, the Awards reflect the analysis of available data on new products and new indications carried out and published by Prescrire during the preceding year.
This year's annual Drug Awards, announced on 26 January in Paris, included not a single winner: no "Golden Pill", no new entries to the "Honours List", not even a "Noteworthy" new drug. Prescrire's annual awards for Drug Packaging and Information were also announced.
At the awards ceremony, a conference-debate was held on the theme "Drug research financed independently of pharmaceutical companies: for better patient care". Financing of drug research by pharmaceutical companies has numerous drawbacks. Independent clinical trials should be developed, in the interest of patients.
For details: see english.prescrire.org
* * *
Prescrire is a non-profit, continuing education organisation that is completely independent of any ties to government or industry. Prescrire's managers and editorial staff sign a yearly statement certifying that they have no conflicts of interest. Prescrire's publications accept no advertising, grants or other outside support or any kind.
Prescrire International is totally funded by subscribers, with no support from the pharmaceutical industry or government. It is monthly and published 11 times a year. Health professionals in low-income countries (excluding drug companies) can benefit from a subscription to Prescrire International thanks to Solidarity Subscription Rates.
You will find full subscription details at english.prescrire.org
Contents of the February issue include:
EDITORIAL